Zhen-Dong Tong

Zhen-Dong Tong

Auto-generated profile, based on publicly available information

Zhen-Dong Tong

Zhoushan Municipal Center for Disease Control and Prevention, Zhoushan, Zhejiang, P.R. China

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Emerging Infectious Diseases
Verified
Journal Article
Open access
ZTZhen-Dong Tong
Zhen-Dong Tong
ATAn Tang
An Tang
KLKe-Feng Li
Ke-Feng Li
PLPeng Li
Peng Li
HWHong-Ling Wang
Hong-Ling Wang
JYJianbo Yan
Jianbo Yan
We report a 2-family cluster of persons infected with severe acute respiratory syndrome coronavirus 2 in the city of Zhoushan, Zhejiang Province, China, during January 2020. The infections resulted from contact with an infected but potentially presymptomatic traveler from the city of Wuhan in Hubei Province.

1 June 2020 in Emerging Infectious Diseases
Verified
Journal Article
Open access
ATAn Tang
An Tang
ZTZhen-Dong Tong
Zhen-Dong Tong
HWHong-Ling Wang
Hong-Ling Wang
YDYa-Xin Dai
Ya-Xin Dai
KLKe-Feng Li
Ke-Feng Li
JYJianbo Yan
Jianbo Yan
We report an asymptomatic child who was positive for a 2019 novel coronavirus by reverse transcription PCR in a stool specimen 17 days after the last virus exposure. The child was virus positive in stool specimens for at least an additional 9 days. Respiratory tract specimens were negative by reverse transcription PCR.

16 March 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
PLPeng Li
Peng Li
JFJi-Bo Fu
Ji-Bo Fu
KLKe-Feng Li
Ke-Feng Li
JLJie-Nan Liu
Jie-Nan Liu
HWHong-Ling Wang
Hong-Ling Wang
JYJianbo Yan
Jianbo Yan
We report a familial cluster of 2019 novel coronavirus disease (COVID-19) to assess its potential transmission during the incubation period. The first patient in this familial cluster was identified during the presymptomatic period, as a close contact of a confirmed patient. Five family members had close contact with this first patient during his incubation period, with four of them confirmed positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the subsequent sampling tests.

1 November 2008 in Accident Analysis & Prevention
Verified
Journal Article
Closed access
VRVirginia Routley
Virginia Routley
JOJoan Ozanne-Smith
Joan Ozanne-Smith
DLDan Li
Dan Li
MYMin Yu
Min Yu
JWJianyue Wang
Jianyue Wang
YQYu Qin
Yu Qin

11 April 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PLPeng Li
Peng Li
ZTZhen-Dong Tong
Zhen-Dong Tong
KLKe-Feng Li
Ke-Feng Li
ATAn Tang
An Tang
YDYa-Xin Dai
Ya-Xin Dai
JYJianbo Yan
Jianbo Yan
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by a novel bunyavirus-SFTSV. The seroprevalence of anti-SFTSV antibodies including immunoglobulin G (IgG) and immunoglobulin M (IgM), specific to SFTSV in the general population has been investigated in various epidemiological studies with inconsistent results. Here, we clarify this discrepancy and reach a more comprehensive result by mean of a meta-analysis. All relevant articles were searched in the electronic databases (PubMed, Web of science, Embase, Chinese National Knowledge Infrastructure database, Chinese Wanfang database) up to November 2016. The pooled seroprevalence and 95% confidence intervals (95% CIs) were calculated by random- or fixed- model on the basis of heterogeneity. In total, 21 studies containing 23,848 blood samples from 7 provinces were included in this meta-analysis. The minimum and maximum reported seroprevalences of SFTSV among humans in China were 0.23% and 9.17%, respectively. The overall pooled seroprevalence of SFTSV antibodies was 4.3% (95%CI: 3.2%-5.5%). The pooled prevalence was 5.9% (95%CI: 4.7%-7.0%) in Zhejiang province, 4.9% (95%CI: 4.1–5.8%) in Anhui province, 3.9% (95%CI: 1.3%-6.4%) in Shandong province, and 0.7% (95%CI: 0.2%-1.1%) in Jiangsu province. Stratified by occupation, the pooled prevalence of farmer was 6.1% (95%CI: 3.4%-8.9%) and others (mainly are students) was 3.3% (95%CI: 2.4%-4.2%). Additionally, seroprevalence of SFTSV in people who lived in the same village with the patient were higher than that of people who lived in a different village. Seropositive rates in sampling years after 2012 were higher than that before 2012. The prevalence of SFTSV did not differ by age or gender. Sensitive analysis by omitting one study at a time indicated the results of the pooled seroprevalence were robust. Seroprevalence of SFTSV among healthy population in central and eastern China is high. Surveillance efforts on mild or asymptomatic infections among endemic persons are needed.

8 September 2016 in Scientific Reports
Verified
Journal Article
Open access
JSJimin Sun
Jimin Sun
ZGZhenyu Gong
Zhenyu Gong
FLFeng Ling
Feng Ling
RZRong Zhang
Rong Zhang
ZTZhendong Tong
Zhendong Tong
JJJianmin Jiang
Jianmin Jiang
Severe fever with thrombocytopenia syndrome (SFTS) is emerging in China and the incidence increased year by year. In this study, we conducted case control study to explore factors associated with SFTS virus (SFTSV) infection and fatal outcome. In the study of factors associated with SFTSV infection, a total of 216 individuals participated the study, including 72 cases and 144 matched controls. There were significant differences in proportion of history of tick bite and breeding domestic animals between cases and controls. Of note, individuals who were unclear whether they had been bitten by ticks had the highest risk of SFTSV infection and odds ratio (OR) was 10.222. In the study of factors associated with SFTS fatal outcome, a total of 129 cases participated the study including 16 deaths and 113 survivors. Significant differences were observed in body mass index (BMI), intervals from illness onset to confirmation, and proportion of gingival hemorrhage between deaths and survivors, whose ORs of these factors were 3.903, 1.996, and 3.826, respectively. Our results suggest that all patients with fever, thrombocytopenia and leukocytopenia in SFTS endemic areas should be suspected of SFTS, even they don’t have history of tick bite, and more intense treatment should be administered to patients with abnormal BMI before laboratory parameters are detected.